Omeros Corporation
Tracked across 1 events · 12 articles · First seen Jul 01, 2026 · Last active Jul 05, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Omeros Corporation is facing a securities fraud investigation by Pomerantz LLP after its stock price fell significantly due to a negative opinion from the European Union — European Medicines Agency regarding its drug narsoplimab. This event negatively impacts the company's reputation and stock value.
Jul 01, 2026 · 12 articles
ERGEN INTELLIGENCE
Track Omeros Corporation live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard